MU
Micron Technology, Inc.
MU has the edge over SRAD overall, supported by stronger valuation and stronger fundamentals.
SRAD
Sportradar Group AG
SRAD's outlook is improving, though it still trails on the overall score.
MU Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
MU's revenue, profitability, cash flow and balance sheet are all currently strong.
SRAD Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
SRAD's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
MU PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 4.6x | $798 | — |
| Cheap | 10x | $777 | -2.7% |
| Current | 11x | $798 | — |
| Fair | 22x | $1,646 | +106% |
| Expensive | 32x | $2,404 | +201% |
Historical ranges are pointers, not guarantees.
MU has the edge over SRAD in the historical PE scenario, which offers more potential upside but is not a forecast.
SRAD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 61x | $3.69 | -71% |
| Fair | 113x | $6.76 | -48% |
| Expensive | 209x | $12.53 | -2.9% |
| Current | 231x | $12.91 | — |
Historical ranges are pointers, not guarantees.
SRAD's PE is 231x, but its earnings don't support one, so it isn't a reliable read right now.
MU Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for MU, with profitability improving.
SRAD Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for SRAD, with profitability improving. However, they disagree widely on these estimates.
MU Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $174.95 | +135% |
| Q3 2026 | $74.33 | +879% |
| Q2 2026 | $44.17 | +693% |
| Q1 2026 | $21.18 | +405% |
| Q4 2025 | $10.52 | +201% |
| Q3 2025 | $7.59 | +984% |
| Q2 2025 | $5.57 | +$6.99 |
| Q1 2025 | $4.19 | +$7.64 |
| Q4 2024 | $3.49 | +$9.77 |
MU has the edge over SRAD on earnings, with more consistent year-over-year improvement.
SRAD Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.06 | -84% |
| Q1 2026 | $0.24 | +14% |
| Q4 2025 | $0.34 | +183% |
| Q3 2025 | $0.32 | +52% |
| Q2 2025 | $0.38 | +375% |
| Q1 2025 | $0.21 | +133% |
| Q4 2024 | $0.12 | +9.1% |
| Q3 2024 | $0.21 | +$0.30 |
SRAD's earnings per share have fallen from their peak: $0.06 over the past year, against $0.38 in mid-2025.
MU Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $54.2B | +379% |
| Q2 2026 | $41.5B | +346% |
| Q1 2026 | $23.9B | +196% |
| Q4 2025 | $13.6B | +57% |
| Q3 2025 | $11.3B | +46% |
| Q2 2025 | $9.3B | +37% |
| Q1 2025 | $8.1B | +38% |
| Q4 2024 | $8.7B | +84% |
MU has the edge over SRAD on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 81% | +48 points |
| Q2 2026 | 80% | +57 points |
| Q1 2026 | 68% | +46 points |
| Q4 2025 | 45% | +20 points |
| Q3 2025 | 32% | +13 points |
| Q2 2025 | 23% | +13 points |
| Q1 2025 | 22% | +19 points |
| Q4 2024 | 25% | +49 points |
MU has the edge over SRAD on profitability, with a higher operating margin.
SRAD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $426.7M | +21% |
| Q1 2026 | $391.3M | +13% |
| Q4 2025 | $406M | +19% |
| Q3 2025 | $324.4M | +14% |
| Q2 2025 | $353M | +14% |
| Q1 2025 | $345.7M | +17% |
| Q4 2024 | $341.1M | +22% |
| Q3 2024 | $283.5M | +27% |
SRAD's revenue has grown year over year every quarter since early 2021: $427M last quarter, up 21% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 10% | +1.5 points |
| Q1 2026 | 7.3% | -0.1 points |
| Q4 2025 | 6.1% | -5.6 points |
| Q3 2025 | 16% | +1.1 points |
| Q2 2025 | 8.8% | -0.8 points |
| Q1 2025 | 7.4% | -5.1 points |
| Q4 2024 | 12% | +7 points |
| Q3 2024 | 15% | +15 points |
SRAD's operating margin was 10% last quarter, up 1.5 points from the same quarter a year ago.
MU Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $32.9B | +45543% |
| Q2 2026 | $17.6B | +951% |
| Q1 2026 | $5.5B | +$5.6B |
| Q4 2025 | $3B | +7853% |
| Q3 2025 | $72M | -75% |
| Q2 2025 | $1.7B | +322% |
| Q1 2025 | -$113M | +$52M |
| Q4 2024 | $38M | +$433M |
MU has the edge over SRAD on cash flow, with more consistent year-over-year improvement.
SRAD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $127.2M | +112% |
| Q1 2026 | $51.1M | +36% |
| Q4 2025 | $21.8M | +$24.3M |
| Q3 2025 | $126.7M | +78% |
| Q2 2025 | $60.1M | -12% |
| Q1 2025 | $37.7M | +1626% |
| Q4 2024 | -$2.5M | -185% |
| Q3 2024 | $71M | +178% |
SRAD generated $327M in free cash flow over the past year, up 96% from the year before.
MU Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -2M shares |
| 1 year | +1.6% | +18M shares |
| 3 years | +4.6% | +50M shares |
| 5 years | +0.2% | +2M shares |
| Available history | +1.2% | +14M shares |
MU has 1.1B diluted shares, up 1.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $350M |
| Q4 2025 | $300M |
| Q3 2024 | $300M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
MU has spent almost nothing on buybacks in the past year.
SRAD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -4.2M shares |
| 1 year | -8.3% | -26.5M shares |
| 3 years | -5.3% | -16.5M shares |
| 5 years | -0.8% | -2.3M shares |
| Available history | -0.8% | -2.4M shares |
SRAD has the edge over MU on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $141.3M |
| Q1 2026 | $101.6M |
| Q4 2025 | $26.7M |
| Q3 2025 | $2.2M |
| Q2 2025 | $69.5M |
| Q1 2025 | $18.5M |
| Q4 2024 | $9.9M |
| Q3 2024 | $8.7M |
SRAD spent $272M buying back its own shares over the past year, up 155% from the year before.
MU Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.3x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | 0.3x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
MU has more cash than debt.
SRAD Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.5x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
| Q3 2024 | -0.8x | Net Cash |
SRAD has the edge over MU on leverage, with a lower net debt burden relative to earnings.
MU Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.1 | Neutral |
| Stochastic | 26.9 | Neutral |
MU's weekly RSI is 47 (neutral) and its Stochastic is 27 (neutral).
SRAD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.1 | Neutral |
| Stochastic | 38.9 | Neutral |
SRAD's weekly RSI is 45 (neutral) and its Stochastic is 39 (neutral).
MU PE vs Technology Sector
| Metric | MU | Sector median | Relative |
|---|---|---|---|
| PE | 11x | 28x | 61% below |
| PE % | 18 | 35 | 17 pts below |
MU has the edge over SRAD on valuation relative to its sector.
SRAD PE vs Technology Sector
| Metric | SRAD | Sector median | Relative |
|---|---|---|---|
| PE | 231x | 28x | 728% above |
| PE % | 87 | 45 | 42 pts above |
SRAD is trading at 231x earnings, a 728% premium to the Technology sector's median of 28x, though its earnings don't support one.
MU Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $914.5 | 13% below |
| 20 week MA | $931.0 | 14% below |
| 50 week MA | $685.9 | 16% above |
| 100 week MA | $405.4 | 97% above |
| 200 week MA | $246.0 | 225% above |
MU has the edge over SRAD on trend strength, trading above more of its moving averages.
SRAD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.5 | 3.4% above |
| 20 week MA | $13.2 | 2.3% below |
| 50 week MA | $15.7 | 18% below |
| 100 week MA | $20.1 | 36% below |
| 200 week MA | $15.9 | 19% below |
SRAD has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 19% below its 200-week average.
MU Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $54.0 | $70.6 | +31% |
| 2021 | $70.6 | $94.4 | +34% |
| 2022 | $94.4 | $50.2 | -47% |
| 2023 | $50.2 | $85.3 | +70% |
| 2024 | $85.3 | $88.6 | +3.9% |
| 2025 | $88.6 | $284.8 | +221% |
| 2026 YTD | $284.8 | $798.4 | +180% |
MU has the edge over SRAD on returns for 2026, with the stronger performance.
SRAD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $27.0 | $18.6 | -31% |
| 2022 | $18.6 | $9.44 | -49% |
| 2023 | $9.44 | $11.1 | +17% |
| 2024 | $11.1 | $17.4 | +58% |
| 2025 | $17.4 | $23.1 | +33% |
| 2026 YTD | $23.1 | $12.9 | -44% |
SRAD is down 44% so far in 2026, after finishing higher in three of the previous five years.